Search Results

DuChemBio Completes Supply Chain for Prostate Cancer Radiopharmaceutical

DuChemBio, a Korean radiopharmaceutical company, announced on August 4 that it has completed the supply chain for ProstaSeek (active ingredient: 18F-plotupolastat), a radiopharmaceutical for prostate cancer diagnosis, in the Yeongnam and Honam regions. The drug targets prostate-specific membrane antigen (PSMA), and all tertiary general hospitals in both regions that perform PET-CT scans and provide prostate cancer diagnosis and treatment have been included in its supply scope. According to data from the National Cancer Registry of the Korean Ministry of Health and Welfare, new prostate cancer cases reached 22,640 in 2023, accounting for 7.8% of all cancer cases and ranking sixth in male cancer incidence; with the increasing adoption of PSMA-targeted therapy, the demand for precise diagnosis before prostate cancer treatment is also growing rapidly.

2026-08-04

United Imaging Healthcare's New-Generation Digital PET/CT "uMI Panvivo" Enters Clinical Use in Japan

August 3 news, United Imaging Healthcare Japan Co., Ltd. announced that the first unit in Japan of its new-generation digital PET/CT scanner uMI Panvivo has been put into clinical use at Saitama Central Clinic, located in Omiya-ku, Saitama City. Saitama Central Clinic is a medical institution specializing in diagnostic imaging. Since its opening in 2009, the clinic has continuously conducted comprehensive cancer screening centered on PET/CT scans, and provides FDG-PET cancer examination services based on the needs of local medical institutions, with an annual PET/CT examination volume ranking among the highest in Japan. With the introduction of uMI Panvivo, the clinic expects to further shorten examination time and enhance image quality on the basis of its existing high-precision diagnostic imaging...

2026-08-03

Radiation protection expert Peter Bryant to lead University of Liverpool's Chadwick Institute for Nuclear Innovation

The University of Liverpool has announced that Professor Peter Bryant has been appointed as the Director of the newly established Chadwick Institute for Nuclear Innovation, with his tenure officially commencing in September 2026. The Chadwick Institute for Nuclear Innovation is named after Nobel laureate Sir James Chadwick, who served as Head of the Physics Department at the University of Liverpool and is renowned for his discovery of the neutron. The Institute will leverage the University of Liverpool's research expertise, innovative facilities, and strategic partnerships in the nuclear energy sector to advance research and talent development in nuclear innovation. Bryant has long been engaged in work related to the civil nuclear fuel cycle, with his research and management portfolio encompassing radiation protection, environmental permitting, radioactive waste...

2026-08-03

Yunnan Caiyunhui Innovation Competition Semifinals Conclude, Irradiation Technology Application Projects Debut

On July 29, the semifinals of the 2026 Caiyunhui Innovation Competition Yunnan Division, themed "Caiyunhui, Win the Future," concluded at Kunming City College. The semifinals covered five industry sectors: next-generation information technology, biomedicine, high-end equipment manufacturing, new materials, new energy, and energy conservation and environmental protection, with 301 enterprises from Yunnan Province advancing to the semifinals. In terms of participant composition, 111 enterprises were in next-generation information technology and 104 in biomedicine, with these two categories accounting for over 70% of the total semifinalists, making them the key tracks of this year's Yunnan Division. In the startup group, projects in next-generation information technology and biomedicine rose to 67%, reflecting that local science and technology innovation projects in Yunnan are extending from traditional industry tracks to emerging industry tracks.

2026-08-01

Curium Advances Second Cyclotron Investment Plan in Romania to Expand PET Imaging Supply

On July 30, Curium announced that it is advancing its second cyclotron investment plan in Romania to expand access to advanced nuclear medicine services locally and further strengthen healthcare infrastructure. According to the introduction, after completing assessments of market opportunities, technical requirements, and regional infrastructure, Curium has identified the Cluj-Napoca region as the preferred site for the project and selected a preferred local partner. Preparatory work is currently underway to support the project's progression to the next phase. This expansion plan aims to increase relevant production capacity, enhance PET imaging equipment and service supply capabilities, improve patient access to advanced diagnostic procedures, and support the...

2026-07-30

Shanghai Petrochemical's Black High-Density Polyethylene Special Material Obtains Nuclear Power Application Qualification

On July 28, Shanghai Petrochemical disclosed that its self-developed black high-density polyethylene special material YGH041TLSH has passed the certification of the American Plastics Pipe Institute (PPI). After passing this certification, Shanghai Petrochemical has become the first domestic supplier of high-end polyethylene pipe materials with nuclear power application qualifications, marking a breakthrough in China's long-term reliance on imports for polyethylene pipe raw materials used in nuclear power water supply and drainage systems. Nuclear power pipelines are one of the important supporting systems of nuclear power plants, with significantly higher requirements for material reliability and safety compared to ordinary municipal pipelines. Taking the 813 mm large-diameter pipeline used in the cooling system of a nuclear power plant as an example, its wall thickness is more than twice that of ordinary pipelines, and the design life requirement reaches...

2026-07-29